ArticleCell biomaterials2026
Approaches for recapitulating the extracellular matrix in organs-on-chip.
Article in Cell biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Recent initiatives to reduce animal use in preclinical research have accelerated the development of organs-on-chip (OoC) for modeling human physiology. While OoCs have advanced structural and cellular complexity beyond 2D culture, strategies to reproduce the extracellular matrix (ECM) remain limited. This review synthesizes emerging strategies to recapitulate native ECM within OoCs, emphasizing both solid and fluid phases of the microenvironment. We define key mechanical parameters governing cell-matrix interactions and outline how these properties are engineered in biomimetic hydrogels. Natural polymers, their modified derivatives, and synthetic polymers are discussed alongside top-down methods using ECM from xenogeneic and human tissues, highlighting tradeoffs among biochemical and biomechanical fidelity, reproducibility, and compatibility with OoC fabrication. By comparing these strategies across tissues and disease models, we identify design principles for engineering ECM that balance physiological relevance with manufacturability, guiding the next generation of OoC platforms toward improved physiological relevance and translational utility.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.